Search research articles
Contact Us
Filters
Showing results (71-80 of 105) with videos related to
Page
of 11
Sort By:
Nature Communications
|
October 23, 2023
Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis
Jonathan W Lo, Domenico Cozzetto, James L Alexander, et al.
Gut
|
December 4, 2019
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Nick Powell, Eirini Pantazi, Polychronis Pavlidis, et al.
Gastroenterology
|
April 29, 2015
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
Nick Powell, Jonathan W Lo, Paolo Biancheri, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
James L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Therapeutic Advances in Gastroenterology
|
August 18, 2025
Non-invasive fluorescence sensing reveals changes in intestinal barrier function and gastric emptying rate in a first-in-human study of Crohn's disease
Jonathan Gan, Qian Chen, Elena Monfort Sanchez, et al.
Gut
|
February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Journal of Crohn'S & Colitis
|
May 1, 2026
What are the top 10 global research priorities for perianal Crohn's disease? The Global Perianal Crohn's Disease Priority Setting Partnership
Theo Pelly, Easan Anand, Jonathan Gower, et al.
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, et al.
Frontiers in Immunology
|
January 23, 2023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia
Grace L Burns, Jessica K Bruce, Kyra Minahan, et al.
Nature Communications
|
October 3, 2022
Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy
Polychronis Pavlidis, Anastasia Tsakmaki, Eirini Pantazi, et al.
Page
of 11
Search research articles
Search
Showing results (71-80 of 105) with videos related to
Sort By:
Page
of 11
Nature Communications
|
October 23, 2023
Immune checkpoint inhibitor-induced colitis is mediated by polyfunctional lymphocytes and is dependent on an IL23/IFNγ axis
Jonathan W Lo, Domenico Cozzetto, James L Alexander, et al.
Gut
|
December 4, 2019
Interleukin-22 orchestrates a pathological endoplasmic reticulum stress response transcriptional programme in colonic epithelial cells
Nick Powell, Eirini Pantazi, Polychronis Pavlidis, et al.
Gastroenterology
|
April 29, 2015
Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation
Nick Powell, Jonathan W Lo, Paolo Biancheri, et al.
Journal for Immunotherapy of Cancer
|
July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximab
James L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Therapeutic Advances in Gastroenterology
|
August 18, 2025
Non-invasive fluorescence sensing reveals changes in intestinal barrier function and gastric emptying rate in a first-in-human study of Crohn's disease
Jonathan Gan, Qian Chen, Elena Monfort Sanchez, et al.
Gut
|
February 26, 2015
Developing in vitro expanded CD45RA+ regulatory T cells as an adoptive cell therapy for Crohn's disease
James B Canavan, Cristiano Scottà, Anna Vossenkämper, et al.
Journal of Crohn'S & Colitis
|
May 1, 2026
What are the top 10 global research priorities for perianal Crohn's disease? The Global Perianal Crohn's Disease Priority Setting Partnership
Theo Pelly, Easan Anand, Jonathan Gower, et al.
The Lancet. Gastroenterology & Hepatology
|
December 8, 2022
Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study
Zhigang Liu, Kaixing Le, Xin Zhou, et al.
Frontiers in Immunology
|
January 23, 2023
Type 2 and type 17 effector cells are increased in the duodenal mucosa but not peripheral blood of patients with functional dyspepsia
Grace L Burns, Jessica K Bruce, Kyra Minahan, et al.
Nature Communications
|
October 3, 2022
Interleukin-22 regulates neutrophil recruitment in ulcerative colitis and is associated with resistance to ustekinumab therapy
Polychronis Pavlidis, Anastasia Tsakmaki, Eirini Pantazi, et al.
Page
of 11